Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ratio Therapeutics Appoints Jacob Hesterman, Ph.D., as Chief Data Officer
Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop […]
As Polio Threatens a Return, UK Expert Calls for Extensive Antibody Testing to Protect Vulnerable Communities
Concerns continue to grow that polio could make a reappearance in the UK. Following the […]
Tridek-one Closes a €16 Million Financing Round to Develop First-in-class Immune Checkpoint Agonists
Tridek-One SAS (the ‘Company’), a leading biotech start-up specialized in the research and development of […]
Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]
GentiBio To Present Preclinical Data Demonstrating Technical Progress to Engineer Regulatory T Cells for the Prevention and Treatment of Autoimmune Diseases
GentiBio, Inc., a biotherapeutics company developing engineered T regulatory (Treg) cells (EngTregs) therapies for autoimmunity, […]
ObvioHealth Introduces ObvioGo, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence
ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo, a next-generation decentralized […]
Ciliatech Presents Groundbreaking Concept in Glaucoma Implants, First to Bypass Opening Anterior Eye Chamber
Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, […]
Monogram Health Donates $2.5M to University of Pennsylvania for Clinical Research Partnership Aimed at Improving Outcomes for People with Chronic Kidney Disease
Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management […]
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer
Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today […]
Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer
Prolifagen Therapeutics, a biotech startup developing medicines for cardiac regeneration, has appointed M. Alexander Shaw, PhD, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more